HOLMDEL, N.J., May 09, 2025 (GLOBE NEWSWIRE) -- BIO-key International, Inc. (NASDAQ: BKYI), an innovative provider of Identity and Access Management solutions with unique Identity-Bound Biometric ...

SILICON VALLEY, CA - June 23, 2026 (NEWMEDIAWIRE) - ABVC BioPharma, Inc. (NASDAQ: ABVC) ("ABVC" or the "Company"), a clinical-stage biopharmaceutical company focused on botanical-derived therapeutics ...

Earnings Call Insights: BIO-key International, Inc. (BKYI) Q3 2025 DePasquale stated, "we expect continuing deployments in orders even this quarter and beyond" with the large banking customer, ...

BIO-key ® International, Inc. (Nasdaq: BKYI), a global leader in Identity and Access Management and biometric authentication technologies, today announced that The Nasdaq Stock Market LLC has notified ...

Detailed price information for Bio-Key International Inc (BKYI-Q) from The Globe and Mail including charting and trades.

CommentaryBIO-key CEO, Mike DePasquale commented, “We had a very productive third quarter, with revenue increasing 18% year-over-year and $1M compared to Q2’24, supported by license fee revenue which ...

BIO-key International, Inc. (OTCQB: BKYI), a global leader in biometric-powered identity and access management (IAM), will participate in an invitation-only cybersecurity and identity workshop hosted ...

Management gave a near-term revenue target rather than full-year guidance: DePasquale said, “we now anticipate Q1 '26 revenue of approximately $2.2 million,” and said Q1 mix should skew toward ...

WALL, N.J., Feb. 03, 2022 (GLOBE NEWSWIRE) --BIO-key International, Inc.(NASDAQ: BKYI), an innovative provider of workforce and customer identity and Access Management (IAM) and Identity-Bound ...

BIO-key is revolutionizing authentication and cybersecurity with biometric-centric, multi-factor identity and access management (IAM) software securing access for over forty million users. BIO-key ...